Simple Summary The use of radioactive iodine (RAI) for the treatment of patients with thyroid
cancer at intermediate risk of recurrence is controversial. Evidence to date has not …

Context The significance of low mitotic activity in papillary thyroid cancer (PTC) is largely
undefined. Objective We aimed to determine the behavioral landscape of PTC with low …

This comprehensive review examines the current controversies regarding diagnosis and
management of intermediate risk differentiated thyroid cancer (DTC). The evolution of risk …

Background Various prognostic factors are expected to refine the American Thyroid
Association recurrence risk stratification for patients with papillary thyroid cancer (PTC) …

Objective The ultrasound evaluation of thyroid nodules (TNs) in patient selection for fine
needle aspiration (FNA) requires both uniformly accepted definitions of each nodule …

Context The utility of thyroglobulin (Tg) in the follow-up of patients with differentiated thyroid
cancer has been well-documented. Although third-generation immunoassays have …

Abstract Objective To compare the American Thyroid Association (ATA) risk staging of
histologically proven papillary thyroid cancer (PTC) in patients who received a presurgery …

Over the past 2 decades, there has been a paradigm shift in the management of
differentiated thyroid cancer (DTC) from the long-time-practiced “one size fits all” approach …

Background For the American Thyroid Association's (ATA) Centennial Annual Meeting, we
presented the Clinical and Surgical Years in Review. The most clinically impactful articles or …

Age is an important component of the American Joint Committee on Cancer TNM staging
system as a predictor of disease specific mortality, with the stratification cutoff of 55 years in …